Investing in Tomorrow’s World-Changers.

A Technology Venture Fund with Private Equity Vision.

Investing in Tomorrow’s World-Changers.

A Technology Venture Fund with Private Equity Vision.






Our Approach

A platform approach to investment.

Safar Partners is a seed- to growth-stage venture fund investing primarily in technology companies out of MIT, Harvard, and the University of Rochester.

We take advantage of the principles of private equity to create value as our companies scale beyond initial prototypes. We accelerate the scaling of our portfolio companies through the formation of spinouts or joint ventures to address additional markets, industries, or geographies.

University Relationships

Deep roots at leading academic institutions.

With access to the most promising technologies developed by the brightest minds, we are often one of the first investors in our portfolio companies, helping them grow and achieve technological and financial success.

Our board is comprised of scholars and experts from Harvard, MIT, and the University of Rochester who are committed to seeing a more efficient technology transfer and faster scaling of ideas that will change the world.

“Working with Safar has been a pleasure – they have been engaged, and were willing to try our product, for which no previous frame of reference existed. Safar is willing to take leaps, shift paradigms, and nurture disruptive technology, and we are thrilled to be part of their portfolio.”

Sharon Samjitsingh

Co-Founder, Health Care Originals

Our Mission

Creating value through innovation.

Tackling the biggest challenges the world is facing today, including climate change and global health, requires vision and global reach. An ever-growing need for new technologies in sustainable energy, clean water, food management, and global health makes solutions in these fields not only impactful but also economically attractive. We founded Safar Partners to invest in the most promising innovations in the cleantech and material science, artificial intelligence and information technology, and life sciences areas. 

In line with our priorities, we have made a public commitment to formally incorporate the consideration of ESG factors into our investment processes and, within the first year of the fund, became a signatory to the United Nations-backed Principles for Responsible Investment (UN PRI

Investment Strategy

Uniquely positioned, our flexible strategy allows us to take technologies from inception to global scale.

Early Stage Investment

Close connections to prestigious universities allow us to access the best technologies early on, maximizing impact and shareholder return.

Flexible model

We are committed to the success of our portfolio companies and support them at all stages of their lifecycle.

A network of experts

Our Scientific and Business Advisory Boards comprise trusted, influential academic and industry leaders who can act as mentors and help our portfolio companies grow.

Our Team

From industry veterans with decades of experience to fresh minds with a drive to change the world, our diverse team is committed to guiding our portfolio companies to financial success and global impact.

Nader Motamedy

Managing Partner & Investment Committee Member

Arunas Chesonis

Managing Partner & Investment Committee Member

Sahba Vaziri

Chief Financial Officer & Chief Operating Officer

Greg S. Feldman

Investment Committee Member
Nader Motamedy is a Managing Partner at Safar Partners. Prior to founding Safar, and until January 1, 2018, Nader was Senior Founding Partner, Chairman, and CEO of Caspian Private Equity (“CPE”), with over $3 billion under management. He led the Investment Team and was a member of the Investment Committee and responsible for the strategic direction as well as the development and management of the firm. During 2018, Nader was Vice Chairman of the Board of Managers of CPE.

Prior to and concurrent to that, until January 2012, Nader was a Founding Partner and member of the Board of Managers of Caspian Capital Management, LLC (“CCM”) which managed as much as $2.2 billion of alternative assets, including fixed income relative value portfolios and quantitative trading strategies. CCM also provided non-discretionary consulting on as much as $3 billion in structured products on funds of hedge fund programs. Nader began his investment career at Morgan Stanley in 1985 and worked at Prudential Securities and CDC Investment Management Corporation prior to founding CCM.

Nader holds an MBA from Boston College and a BS in Mechanical Engineering from Boston University. He serves on various company and fund advisory boards. In addition to other community engagements, he is also actively involved in several youth assistance and development projects. Nader was instrumental in establishing the Paris St. Germain professional soccer team youth development program and its Foundation in the United States to help underprivileged youth achieve their athletic as well as academic potential. He is also a senior advisor to Inter Campus, the philanthropic arm of Inter Milan soccer team in New York as well as the Youri Djorkaeff Foundation. Nader is also the president of the Boston Children’s Fund.

Arunas Chesonis is a Managing Partner on the investment team at Safar Partners. He has a long history in sustainability and has supported numerous environmental and renewable energy research projects at the Massachusetts Institute of Technology to address climate change. He has also personally invested in the past 10 years in cleantech, life sciences, and information technology ventures through his involvement at universities in Boston and Rochester. Arunas also serves as CEO of Sweetwater Energy. Prior to Sweetwater, he served as Chairman and Chief Executive Officer of PAETEC Holding Corp., a Fortune 1000 telecommunications company acquired in 2011 by Windstream Corp. (NASDAQ: WIN), one of the largest national telecom carriers. Arunas founded PAETEC in 1998.

He holds a B.S. in Civil Engineering from MIT, an MBA from the William E. Simon Graduate School of Business at the University of Rochester, and an Honorary Doctorate of Laws from the University of Rochester. Arunas is also a member of the M.I.T. Corporation and is a life trustee of the University of Rochester.

Sahba Vaziri is the Chief Financial Officer and Chief Operating Officer at Safar Partners. Shaba also spearheads the ESG efforts at Safar Partners..

Sahba is a successful finance professional in the energy field, focusing on renewable energy. She has 20 years of experience financing power projects, both as a banker at Lehman Brothers, CS First Boston Corporation, and Bechtel Corporation, and as a personal investor.  Most recently, Sahba worked as a financial consultant to the leading marine hydrokinetic energy company, Ocean Renewable Power Company, where she analyzed financial and market conditions, performed due diligence, and raised private and public financing.

Sahba is a dual degree holder from MIT. She received her MBA from Sloan School of Management, with Concentrations in Finance and International Management. She also has a BSc in Electric Engineering from MIT with concentrations in Optoelectronics and Telecommunications. Sahba is involved with community volunteering, as a member of the Ethel Walker School Board of Trustees, the President of the 1172 Park Avenue Corporation Board of Directors, and a member of Mission: Restore Advisory Board.

Greg Feldman co-founded Wellspring in 1995. Areas of investment focus for Greg include retail, restaurants and consumer products and services where he has led numerous transactions for Wellspring.

For four years prior to the formation of Wellspring, he was in charge of acquisitions at EXOR America Inc., the U.S. investment arm of the Agnelli Group. For two years before joining EXOR, Greg was vice president and co-founder of Clegg Industries, Inc., an investment firm backed by Drexel Burnham Lambert Incorporated to invest in leveraged acquisitions of middle market manufacturing companies. From 1983 to 1988, Greg was a mergers and acquisitions lawyer at Paul, Weiss, Rifkind, Wharton & Garrison in New York.

Greg has served on the boards of more than twenty public and private companies. In addition to his for-profit board activities, Greg also serves as President of the Board of The Kitchen and Co-Head of the Director’s Council at The Whitney Museum of American Art. Greg received a Bachelor of Arts degree from Hampshire College and a JD from the Benjamin N. Cardozo School of Law, where he was Editor-in-Chief of the Law Review. Greg and his wife have three children and live in New York City. Greg Feldman is a member of the Investment Committee and non-employee of Safar Partners.

Ayman Hindy, Ph.D.

Operating Partner

Rob Fleischman

Operating Partner

Vera Schroeder, Ph.D.

Partner – Venture Investor

Parinaz Motamedy

Partner – Venture Investor

Ayman Hindy is an operating partner at Safar Partners. Ayman has long and extensive experience in the investment management and hedge fund industry together with teaching and research activities in leading business schools.   

Ayman was a partner at Advanced Liquidity Concepts, LLC, an investment firm specialized in liquidity trading later purchased by Point72 Asset Management. Ayman developed theoretical and empirical systems for measuring and optimizing liquidity trading costs. Prior to that, he was a Partner, Senior Portfolio Manager, and Head of the U.S. Office for Capula Investment Management, a global firm with over $14BB in assets.  He oversaw all business and regulatory issues in the US, served as a discretionary senior portfolio manager, led risk management and the development of global fixed income relative value and macro strategies.  Ayman was also a Founding Partner & Portfolio Manager at Platinum Grove Asset Management, a global investment firm with 8BB of assets. He served as a member of the Management Committee and Capital Allocation Committee and was Chair of the Credit Committee which was responsible for managing relationships with trading counterparts. He hired and trained trading teams focused on relative value and macro trading strategies. Ayman started his investment career as a senior strategist at Long-term capital management where he developed relative value models, mortgage prepayment models, and credit models and invested in European markets, US mortgage bonds and derivatives, and traded relative value in emerging markets.  

Ayman holds a master’s degree in Engineering and Ph.D. in financial economics, both from MIT. He served as assistant and associate professor of finance at the Graduate School of Business, Stanford University.  He has many research publications in leading academic journals and continues to serve as a guest lecturer at leading business schools. He served on the advisory board of the Cairo Stock Exchange and the visiting committee at the American University in Cairo.   


Rob Fleischman is a successful technology entrepreneur and has deep knowledge in the areas of Internet Infrastructure, Distributed Systems, Artificial Intelligence, Security, Networking, and Very Large Scale Server Development. 

After graduating from MIT (SB in Computer Science, SM in Computer Science and Electrical Engineering), Rob began his career at BBN Labs (where the Internet was invented, in fact, Rob’s first mentor was Ray Tomlinson, the inventor of e-mail). 

Mr. Fleischman founded multiple start-ups, and held senior engineering positions at large technology and financial companies (BBN, Fidelity, Highwind,, Openwave, Sandvine, Xerocole, Akamai, and others).  He holds many patents, invented and helped build news, messaging and DNS technologies that currently process trillions of transactions daily on the Internet. 

Mr. Fleischman is currently a valued advisor on the boards of multiple technology companies and leads multiple endowment investment committees.  In addition, Rob is currently a Tiger 21 chair in Boston where he helps UHNW investors, families, and financial advisors discuss investments, family wealth issues, and philanthropy. 

For many years, for fun, Rob could be heard on the radio as a guest and contributor to NPR in New England as the “explainer of all things wired”.  Finally, and most importantly, Rob is a dedicated husband and father (2 daughters) and works hard to maintain an active life in New Hampshire. 


Vera Schroeder is an Associate and Venture Investor at Safar Partners. Vera brings broad experience in the fields of chemistry, nanoscience and materials science to the Safar team. As a graduate student, she worked in the laboratory of Professor Tim Swager at MIT focused on carbon-nanotube based chemical sensing. While at MIT, she also spent her time at Sloan and HBX learning about venture creation and strategy as well as interning at MP Healthcare Venture Management fund. She holds a BS in Chemistry and an MS in Chemistry from RWTH Aachen University, and a Ph.D. in Chemistry from MIT.


Parinaz Motamedy is an Associate and Venture Investor at Safar Partners. Prior to joining Safar, Parinaz worked at Accorhotels in Paris, investing in hospitality startups on Accor’s corporate venture team. Before Accor, Parinaz worked on the Product Structuring Team at Blackstone, structuring specialized hedge fund products at Blackstone Alternative Asset Management in New York City. Parinaz has a BA in Philosophy and a secondary in Psychology from Harvard University.


Richard Swartwout, Ph.D.

Venture Investor

Sanlin Robinson, Ph.D.

Venture Investor

Tony Cheung

Manager of Systems & Operations 

Leslie Hartford

Manager of Administration

Richard Swartwout is an Analyst and Venture Investor at Safar Partners. Richard has a Ph.D. in Electrical Engineering at MIT focusing on manufacturing challenges of various solution-processed large area thin films with a focus on thin-film optoelectronic technology.  He also holds a Masters in Electrical Engineering from MIT, during which he focused on low-cost replacements to traditional ceramic transparent conductors. Prior to Safar and MIT, Richard received a B.A. in Materials Engineering from Rensselaer Polytechnic Institute.  He has also worked in multiple start-ups during his academic and professional career.

Sanlin Robinson is an Analyst and Venture Investor at Safar Partners. Most recently she worked as a postdoctoral fellow in Jennifer Lewis’ laboratory at Harvard, where she engineered kidney-on-chip perfusion systems. Previously, she received a Ph.D. in materials science and engineering from Cornell. While at Cornell, she worked in Rob Shepherd’s Organic Robotics Lab on soft materials and additive manufacturing. Specifically, she developed a patient-specific cardiac device and a synthetic sensory-motor analog that can be 3D printed.

Tony Cheung is the Manager of Systems and Operations. Since 2013, he has consulted for various private equity firms, hedge funds, and startups primarily advising and implementing information technology, operations, and business processes. Prior to that, he worked as a Trade Analyst at Caspian Capital Management, which managed as much as $2.2 billion of alternative assets. Tony holds a B.S. in Information Technology from Rensselaer Polytechnic Institute.  


Leslie Hartford is the Manager of Administration at Safar Partners. She brings extensive experience in executive, financial and legal administration to the Safar team. Leslie has over 20 years of experience working directly with corporate executive and legal teams at AIG, Inc., PAETEC Corp., and Sweetwater Energy, Inc. She holds a BA in Sociology from Le Moyne College, a Paralegal Certification from Syracuse University, and a MBA from the Madden School of Business at Le Moyne College. 


Safar Principals have been extremely helpful with building Gradiant’s network. They care and make it easy to discuss both positives and negatives candidly to come up with solutions to complex issues. They know the path isn’t always straight.

Anurag Bajpayee

CEO & Co-Founder, Gradiant Corporation

Scientific Advisory Board

Influential academic leaders dedicated to advancing new technologies.

Danielle Benoit

University of Rochester

Professor of Biomedical Engineering

Markus J. Buehler


Former Department Head of Civil and Environmental Engineering & McAfee Professor of Engineering 

Vladamir Bulović


Fariborz Maseeh Chair in Emerging Technology and MIT School of Engineering’s Associate Dean for Innovation

Robert L. Clark

University Of Rochester

Provost & Senior Vice President for Research

Danielle Benoit is a Professor within the Department of Biomedical Engineering with appointments also in Chemical Engineering and the Center for Musculoskeletal Research and is also the Director of Materials Science Program at the University of Rochester.  She directs the Therapeutic Biomaterials Laboratory, which specializes in the rational design of polymeric materials for regenerative medicine and drug delivery applications.  Her work has provided insights into the translation of tissue engineering strategies for bone allograft repair, the development of pH-responsive nanoparticles for nucleic acid and small molecule drug delivery, and novel targeting strategies for bone-specific delivery of therapeutics.  Prof. Benoit has been recognized by numerous awards and accolades for her research program including the 2019 Class of AIMBE Fellows, the 2018 University of Maine Distinguished Alumni Award, the 2016 Kate Gleason Young Engineer of the Year Award, a 2015 Young Innovator Award in Cellular and Molecular Bioengineering, an NSF CAREER Award, and Alex’s Lemonade Stand Young Investigator Award. She is also a standing member of the NIH Biomaterials and Biointerfaces Study Section. Prof. Benoit received her undergraduate degree in Biological Engineering from the University of Maine and M.S. and Ph.D. in Chemical Engineering from the University of Colorado, where she was mentored by Dr. Kristi Anseth. She then trained at the University of Washington where she was the Merck Fellow of the Damon Runyon Cancer Research Foundation, working with Drs. Patrick Stayton and Allan Hoffman.  Prof. Benoit joined the faculty at the University of Rochester in 2010.   

Markus J. Buehler is Former Department Head of Civil and Environmental Engineering & McAfee Professor of Engineering at MIT. He also directs the Laboratory for Atomistic and Molecular Mechanics (LAMM) and serves as the Director of the MIT-Germany Program. Until 2013, he served as Co-Director of the MIT Computation for Design and Optimization Program.

Buehler has published more than 300 articles and delivered hundreds of plenary, keynote and invited speeches. Buehler received the NSF CAREER award, the United States Air Force Young Investigator Award, the Navy Young Investigator Award, and the DARPA Young Faculty Award, as well as the Presidential Early Career Award for Scientists and Engineers (PECASE). In 2010 he received the Harold E. Edgerton Faculty Achievement Award for exceptional distinction in teaching and in research or scholarship. Other awards include the TMS Hardy Award, the IEEE Holm Conference Mort Antler Lecture Award, the Materials Research Society Outstanding Young Investigator Award, the SES Young Investigator Medal, the Thomas J.R. Hughes Young Investigator Award, the Sia Nemat-Nasser Medal, the Rossiter W. Raymond Memorial Award, the Stephen Brunauer Award, the Alfred Noble Prize, and the Leonardo da Vinci Award. Buehler serves as a member of the editorial board of many international publications and has chaired numerous committees.

He received a Ph.D. in Chemistry from the University of Stuttgart and the Max Planck Institute for Metals Research after obtaining a M.S. in Engineering Mechanics from Michigan Tech, and undergraduate studies in Chemical and Process Engineering at the University of Stuttgart.

Vladimir Bulović joined the faculty of MIT in July 2000 and is the Fariborz Maseeh (1990) Professor of Emerging Technology and the MIT School of Engineering’s Associate Dean for Innovation. He leads the Organic and Nanostructured Electronics Laboratory and is co-director of the eni-MIT Solar Frontiers Center and MIT’s Innovation Initiative.

Bulović’s research interests include studies of physical properties of organic and organic/inorganic nanocrystal composite thin films and structures, and development of novel nanostructured optoelectronic devices. He is an author of over 140 research articles (cited over 10,000 times) and an inventor of over 50 U.S. patents in areas of light emitting diodes, lasers, photovoltaics, photodetectors, chemical sensors, programmable memories, and micro-electro machines, majority of which have been licensed and utilized by both start-up and multinational companies.

He is a founder of QD Vision, Inc. of Watertown MA which is producing quantum dot optoelectronic components, of Kateeva, Inc. of Menlo Park CA which is focused on development of printed organic electronics, and Ubiquitous Energy, Inc. which is developing nanostructured solar technologies. Prof. Bulović received his M.S. Degree from Columbia University in 1993 and his Ph.D. from Princeton University in 1998.

Robert Clark became provost in July 2016 after serving 8 years as dean of the Hajim School of Engineering & Applied Science. He has also carried the title of senior vice president for research since 2012. Prior to his appointments at the University of Rochester, Clark spent 16 years of his academic career at Duke University where he served as senior associate dean for 6 years and then dean of the Pratt School of Engineering.

Clark received a BS degree in 1987 and an MS degree in 1988 both in mechanical engineering from the Virginia Polytechnic Institute and State University before joining Michelin Research in Greenville, South Carolina. He returned to Virginia Tech to complete his doctoral work and received his PhD in 1992.

Clark is an expert in acoustics and bionanomanufacturing. He has over 130 journal publications and has been awarded the R. Bruce Lindsey Award from the Acoustical Society of America, the National Science Foundation Career Program Award, the Presidential Early Career Award for Scientists and Engineers, the NASA Group Achievement Award, and in 2016 was named Engineer of the Year by the Rochester Engineering Society.

He currently serves on the board of Minerals Technologies Incorporated, Sweetwater Energy, GW Lisk, and is a member of the Strategic Advisory Board for the Austrian Institute of Technology. Clark served as Chief Science/Technology Officer for bsg technologies from 2009-2013, was a co-founder for Spark IP, and has extensive consulting experience in the technology space.

Reza Dana

Harvard Medical School, Mass. Eye and Ear

Claes Dohlman Professor of Ophthalmology at Harvard Medical School, and Director of Cornea at the Massachusetts Eye and Ear

Richard McCullough


Professor of Materials Science and Engineering and Vice Provost of Research

Christopher Schuh


Former Department Head of Materials Science and Engineering & Danae and Vasilis Salapatas Professor of Metallurgy

Timothy M. Swager


Former Department Head of Chemistry, Director of The Deshpande Center for Technological Innovation & Professor of Chemistry

Reza Dana is the Claes Dohlman Professor of Ophthalmology at Harvard Medical School, and Director of Cornea at the Massachusetts Eye and Ear, and Senior Scientist at the Schepens Eye Research Institute of Mass Eye and Ear, where he leads the Laboratory of Corneal Immunology, Transplantation and Regeneration. In addition, he is a faculty member of the Immunology graduate program at Harvard Medical School and Director of the Harvard-Vision Clinical Scientist Development Program.

A graduate of Johns Hopkins and Harvard, his work focuses on disease mechanisms that underlie autoimmunity, tissue scarring, transplant failure, chronic inflammation, and pathological blood vessel formation. He has authored over 400 articles and his published work has been cited more than 26,000 times. He has been recipient of numerous awards, including the Association for Research in Vision and Ophthalmology Cogan and Friedenwald Awards, the Physician-Scientist Award, Senior Investigator Award and the Stein Innovation Award from Research to Prevent Blindness, the Alcon Research Institute Award, the Endre A. Balazs Prize from the International Society of Eye Research, and the Ellis Island Medal of Honor for his contributions in the United States.

He is Editor-in-Chief of Cornea, Senior Associate Editor of Ocular Surface, and Senior Editor of Encyclopedia of the Eye. In addition to his basic investigations, he leads a translational research program that has received 12 IND permits from the US FDA. He has trained over 120 fellows and graduate students from 34 countries in his laboratory, and over 80 physician fellows to date. He is recipient of the A. Clifford Barger Excellence in Mentoring Award at Harvard Medical School.

Reza Dana has launched multiple new programs in biotechnology, and has co-founded several new enterprises including Eleven Biotherapeutics, Claris Biotherapeutics, Aramis Biosciences, and Boston Eye Diagnostics.

Richard McCullough, Ph.D. has a B.S. in chemistry from the University of Texas, Dallas, earned his M.A. and Ph.D. in chemistry at Johns Hopkins University. He did his postdoctoral fellowship at Columbia University.

Since 2012, Dr. McCullough has been the Vice Provost for Research, working with the President and Provost to encourage, cultivate, and coordinate high impact academic research across all of Harvard’s schools and affiliated institutions. The Office of the Vice Provost for Research (VPR) has broad responsibility and oversight for the development, review, and implementation of strategies, planning, and policies related to the organization and execution of academic research across the entire university. Dr. McCullough leads a new office of Foundation and Corporate Development. He also assists in oversight of many of the interdisciplinary institutes, centers and initiatives across Harvard.

Under Vice Provost McCullough’s leadership, the Office of the VPR is particularly focused on removing barriers to collaboration, whether in University policies, or financial or administrative systems. Additionally, the Vice Provost for Research works with the President and Provost to foster and encourage entrepreneurship among undergraduates, graduate students, and faculty members. He also helps to lead the development of the new innovation campus.

Richard McCullough is Professor of Materials Science and Engineering at Harvard and is a member of numerous professional societies and boards.

Prior to being named Vice Provost for Research at Harvard, Dr. McCullough was the Vice President for Research at Carnegie Mellon University in Pittsburgh, where he previously served as the Dean of the Mellon College of Science, and Professor and head of the Department of Chemistry. Dr. McCullough has founded two companies: Plextronics Inc, and Liquid X Printed Metals.

Christopher A. Schuh is the Department Head and the Danae and Vasilis Salapatas Professor of Metallurgy in the Department of Materials Science and Engineering at MIT. Schuh’s academic training in Materials Science and Engineering focused on metals, including their processing, microstructure, and mechanics. He earned his B.S. degree from the University of Illinois at Urbana-Champaign in 1997, and his Ph.D. from Northwestern University in 2001. He held the Ernest O. Lawrence postdoctoral fellowship at Lawrence Livermore National Laboratory in 2001 before moving to join the faculty at MIT in 2002.

Prof. Schuh has co-founded a number of metallurgical companies. His first MIT spin-out company, Xtalic Corporation, commercialized a process from Schuh’s MIT laboratory to produce stable nanocrystalline coatings, which have now been deployed in over 10 billion individual components in use worldwide. Prof. Schuh’s startup Desktop Metal is a metal additive manufacturing company developing 3D metal printers that are sufficiently simpler and lower-cost than current options to enable broad use across many industries. Recently, Schuh co-founded Veloxint Corporation, which is commercializing machine components made from custom stable nanocrystalline alloys designed in his MIT laboratory.

Prof. Schuh also currently serves as the Coordinating Editor of the Acta Materialia family of journals. He has been named a MacVicar Fellow of MIT, acknowledging his contributions to engineering education, and is an elected Fellow of ASM and TMS.

Dr. Swager is the John D. MacArthur Professor of Chemistry at the Massachusetts Institute of Technology and the director of the Deshpande Center for Technological Innovation. His research is at the interface of chemistry and materials science, with specific interests in carbon nanomaterials, polymers, and liquid crystals. He is a member of the National Academy of Sciences and American Academy of Arts and Sciences.

Swager earned his B.S. in Chemistry from Montana State University, received a Ph.D. from the California Institute of Technology working with Robert H. Grubbs, and performed postdoctoral studies at the Massachusetts Institute of Technology under Mark S. Wrighton. He began as an Assistant Professor at the University of Pennsylvania in 1990 and returned to MIT in 1996 as a Full Professor.

Swager is best known for advancing new chemical sensing concepts based on molecular electronic principles. He introduced the concepts of charge and energy transport through molecular and nanowires as a method to create amplified signals to chemical events. These methods gave rise to the sensitive explosive sensors that have been commercialized under the trade name Fido. He demonstrated the integration of molecular recognition into chemiresistive sensors, first with conducting polymers and later with carbon nanotubes, and these methods were commercialized by C2Sense.

Sophie Vandebroek

Strategic Vision Ventures 

Founder and Owner of Strategic Vision Ventures, Member of MIT’s Dean of Engineering Advisory Council, Former IBM and Xerox executive 

Conor Walsh


Paul A. Maeder Professor of Engineering and Applied Sciences at the John A. Paulson Harvard School of Engineering and Applied Sciences and Associate Faculty Member at the Wyss Institute for Biologically Inspired Engineering 

Sophie Vandebroek is founder and owner of Strategic Vision Ventures LLC, a strategic advisory firm working with clients worldwide. Most recently, Sophie served as the Chief Operating Officer of IBM Research where she was instrumental in creating the MIT-IBM Watson AI Lab. Previously, Sophie was Xerox’s Chief Technology Officer and led Xerox’s global laboratories, including PARC, Inc., an innovation services company for over a decade.  


In 2019, Sophie became the Inaugural School of Engineering Visiting Scholar at MIT. She has been a member of the Advisory Council of the Dean of Engineering at MIT for the past decade. She is also a trustee at the Boston Museum of Sciences and a member of the International Advisory Board of the Flanders AI Research Program. Sophie is a member of the Board of Directors of IDEXX Laboratories, the global leader in veterinary diagnostics, and on the Supervisory Board of Wolters Kluwer, a global provider of professional information, software solutions, and services. 


Sophie is a Fellow of the Institute of Electrical & Electronics Engineers, an inductee into the Women in Technology International Hall of Fame and elected member of the Royal Flemish Academy for Arts & Sciences. Sophie’s passion for creating inclusive organizations where innovation thrives has earned her many awards among which is Xerox’s Inaugural Lifetime Diversity Leadership Award of Distinction.  


Sophie grew up in Belgium and earned a master’s degree in Engineering Magna from KU Leuven, Belgium and a Ph.D. in Engineering from Cornell University, Ithaca, New York. 

Conor Walsh is the Paul A. Maeder Professor of Engineering and Applied Sciences at the John A. Paulson Harvard School of Engineering and Applied Sciences and an Associate Faculty Member at the Wyss Institute for Biologically Inspired Engineering. He is the founder of the Harvard Biodesign Lab, which brings together researchers from the engineering, industrial design, apparel, clinical, and business communities to develop new disruptive robotic technologies for augmenting and restoring human performance. This research includes new approaches to the design, manufacture, and control of wearable robotic devices and characterizing their performance through biomechanical and physiological studies so as to further the scientific understanding of how humans interact with such machines. Example application areas include enhancing the mobility of healthy individuals, restoring the mobility of patients with gait deficits, assisting those with upper extremity weakness to perform activities of daily living, and preventing injuries of workers performing physically strenuous tasks. His multidisciplinary research spans engineering, biology, and medicine and has led to multiple high impact scientific papers as well as technology translation. Multiple technologies from the lab have been licensed to industry. He is a co-founder of Verve, Inc. commercialization of a back assist exosuit and the ReStore soft exosuit from ReWalk Robotics is now FDA and CE mark approved for use during gait rehabilitation poststroke. He is the winner of multiple awards including the Presidential Early Career Award for Scientists and Engineers and the MIT Technology Review Innovator Under 35 Award.

Business Advisory Board

Industry veterans to guide our portfolio companies to financial success and global reach.

Sébastien Bazin


Chairman & CEO

Chair of Strategic Partnerships, Safar Partners

Anurag Bajpayee

Gradiant Corporation

Co-Founder & CEO

Mark Chaney

Calvary Robotics

Co-Founder & CEO

Robert P. Cochran

Build America Mutual

Managing Director & Chariman of the Board

After five years working in several financial positions in New York, San Francisco and London, Sébastien Bazin was appointed CEO of Hottinguer Rivaud Finances, an investment bank, in 1990, and then CEO of L’Immobilière Hôtelière, a hotel developer in France, in 1992. In 1997, he moved to Colony Capital, a private real estate investment firm, to head up its European branch and lead several acquisitions, principally in the hospitality sector (Générale des Eaux, Club Méditerranée, Lucien Barrière, Fairmont & Raffles, Buffalo Grill, Château Lascombes, Stadia Consulting and others).

He joined Accor’s Board of Directors in 2005 and, via Colony Capital, became a Paris Saint-Germain shareholder in 2006 and the club’s Chairman in 2009.

In August 2013, he resigned from his duties at Colony Capital and was appointed Chairman and CEO of Accor.

Sébastien has been Chairman of the Théâtre du Châtelet’s Board of Directors since 2015 (and a Board member since 2013), is Vice-Chairman of the Gustave Roussy Foundation’s Supervisory Board, and has been a member of GE’s Board of Directors since 2016.

Anurag Bajpayee is the co-founder and CEO of Gradiant Corporation. Under his leadership, Gradiant has evolved from a technology start-up to a global brand with multiple divisions and office locations around the world. Gradiant is a provider of technology-driven water services intended to promote sustainable energy consumption. The company’s technology-driven water services includes gas extraction system which helps to decontaminate the water produced in gas and oil wells, as well as desalination technology, brine minimization systems and disinfection products, enabling clients to promote safe water disposal and industrial wastewater treatment.

Prior to founding Gradiant, Anurag received his PhD in mechanical engineering from the Massachusetts Institute of Technology.


Mark Chaney is passionate about holding strong values and uniting leadership positions within the company to follow through with the vision of Calvary through its employees and customers that they serve. Under Mark Chaney’s leadership, Calvary Industries has grown and expanded during periods of economic and industrial challenges and has been able to forge business relationships internationally to expand their market. The company has nearly doubled in the past year and a half, and grown to almost 300 employees.

Mark’s commitment to innovation has spawned a new Innovation lab which has developed new products such as Opti-Cool (Energy efficient Data Center Cooling Equipment) and X-Cell (Modular and Redeployable Assembly Equipment). Bringing high technology to manufacturing automation, machine tooling and robotics is important to the future of Calvary.

Mark bases a high level of importance on the values of reliability, integrity, high quality, honesty and respect for all employees and customers, as well as takes a strong personal interest in helping set strategies for continued growth and success for Calvary’s Market with executive leaders in the company.

Bob Cochran co-founded Build America Mutual Assurance Company, the first mutual municipal bond insurer, in July 2012. Prior to that, he was a co-founder of Financial Security Assurance (FSA) and was CEO from 1990 to 2009 (NYSE: FSA from 1994 to 2000). On joining FSA in 1985, he headed the Financial Guaranty Department and, in that role, led the Company in establishing its underwriting and risk management criteria. In 1990, the board appointed him Chief Executive Officer, successor to Jim Lopp, FSA’s principal founder. He also chaired the Association of Financial Guaranty Insurers from 2001 to 2002. Mr. Cochran joined FSA from the law firm Kutak Rock, where he was a public finance lawyer and Managing Partner of the Washington, DC office. In July 2013, Bob was named to the Board of Directors of the Municipal Securities Rulemaking Board (MSRB).

He graduated from Centre College (BA,’71) and Duke University School of Law (JD), followed by a federal judicial clerkship for Judge Pierce Lively (6th Circuit Court of Appeals).


Shreya Dave

via separations

Co-Founder & CEO

Greg S. Feldman

Wellspring Capital Management

Executive Chairman

Investment Committee Member, Safar Partners

Nicolas Fourt


Deputy CEO

Natalie Givans

Booz allen hamilton

Partner (Retired)

Shreya Dave graduated from MIT with a PhD in Mechanical Engineering and currently serves as CEO of Via Separations. Her PhD research focused on the design and manufacture of graphene oxide membranes for water desalination, including fundamental characterization methods of graphene oxide, membrane synthesis, and economic analysis of the role of membranes in cost constraints of desalination plants. Via Separations is scaling up and commercializing the material platform for use in industrial separation processes such as food ingredient production and chemical manufacturing.

She also holds bachelor’s and master’s degrees from MIT in mechanical engineering and technology & policy.


Greg Feldman co-founded Wellspring in 1995. Areas of investment focus for Greg include retail, restaurants and consumer products and services where he has led numerous transactions for Wellspring.

For four years prior to the formation of Wellspring, he was in charge of acquisitions at EXOR America Inc., the U.S. investment arm of the Agnelli Group. For two years before joining EXOR, Greg was vice president and co-founder of Clegg Industries, Inc., an investment firm backed by Drexel Burnham Lambert Incorporated to invest in leveraged acquisitions of middle market manufacturing companies. From 1983 to 1988, Greg was a mergers and acquisitions lawyer at Paul, Weiss, Rifkind, Wharton & Garrison in New York.

Greg has served on the boards of more than twenty public and private companies. In addition to his for-profit board activities, Greg also serves as President of the Board of The Kitchen and Co-Head of the Director’s Council at The Whitney Museum of American Art. Greg received a Bachelor of Arts degree from Hampshire College and a JD from the Benjamin N. Cardozo School of Law, where he was Editor-in-Chief of the Law Review. Greg and his wife have three children and live in New York City. Greg Feldman is a member of the Investment Committee and non-employee of Safar Partners.

Nicolas Fourt has a 30 + years  high level experience in capital markets, banking and asset management. He was global head of capital markets at Natixis until August 2008, having managed these activities previously at CDC and then IXIS where he served as an executive board member. He pushed Natixis to bridge the gap between markets and banking by developing specific expertise in the securitisation market (insurance, receivables) and by financing infrastructure, real estate and LBO participants. While at Natixis, he also chaired NAII, an alternative fund management structure, that later spun off  infrastructure and real estate asset management companies Mirova, Cube, and Captiva.

Nicolas oversaw the acquisition from Temasek of Singapore of structured finance activity  Nexgen in 2005. He co-managed the Lazard-Natixis joint venture from 2006 onwards. As CEO of advisory boutique Alfafinance between 2009 and 2014, he was more specifically involved in debt restructuring and advisory of major clients in banking  and insurance sectors. He merged Alfafinance with asset management company Acofi in 2014 to set up an innovative direct lending platform managing $2 billion in real estate, energy, SME, and early stage innovation actors in Europe.

Nicolas is a graduate from French National Statistics School, holder of a Masters in Economics from Université de Paris Sorbonne, and a chartered actuary.

Recently retired as a Partner/Senior Vice President from Booz Allen Hamilton in McLean VA, Natalie Givans has 33 years of experience in large program business development and leadership of functional teams (such as Cybersecurity) as large as 2000 staff and over $300M annual revenue. Her technical skills span a wide range of IT systems and cybersecurity including system security engineering, privacy, information and mission assurance. During the past 5 years she has worked with civilian and military health care organizations to help them specify, acquire, and operate their Health IT systems, privacy and security, and electronic health record systems and standards. She is a subject matter expert in cyber security and privacy across the defense, national security, civilian agency, and health domains.

Natalie has been a member of the Armed Forces Communications and Electronics Association (AFCEA International) for 31 years, and chaired its board of directors from 2010 to 2012. She is a Member of AFCEA’s Educational Foundation and AFCEA International’s Governance Committee. She also serves on the Johns Hopkins University Whiting School of Engineering National Advisory Board. She was named Engineer of the Year by the District of Columbia Council of Engineering and Architectural Societies for 2009 and one of Diversity Journal’s Women Worth Watching in 2011. She also earned the Suzanne Jenniches Award from the Society of Women Engineers for her work in helping women to succeed in engineering and technology.

She holds a B.S. in electrical engineering from MIT, and an M.S. in electrical engineering from the Johns Hopkins University.


Seth W. Lawry

Thomas h. lee partners

Advisory Partner

Chris O'Donnell

OAM Quant 

Founder and CEO 

Bijan Salehizadeh

NaviMed Capital

Co-Founder & Managing Director

Mark Zupan

Alfred university


Seth Lawry is a private investor and Advisory Partner at Thomas H. Lee Partners, which he joined in 1989.  During his nearly 25 years at THL, Seth was a Managing Director and a member of the firm’s management committee, investing in a variety of companies across Business Services, Financial Services, Information Services, Media and Technology.  Seth also worked at Morgan Stanley in the Mergers and Acquisitions, Corporate Finance, and Equity Capital Markets departments and at General Atlantic Partners, a Venture Capital firm.

Seth’s twenty years of corporate board service spans both public and private companies. He has also served as a trustee of Colby College for twelve years and is active in other private and non-profit institutions.

Seth holds a B.A. in Economics and German Studies from Williams College and an M.B.A. from the Stanford Graduate School of Business.


Chris O’Donnell is the Founder and Chief Executive Officer of OAM Quant, an investment management company whose aim is to consistently generate alpha in liquid global markets using a disciplined approach rooted in data science, technology, and finance.   

Chris has in excess of 25 years of investment and entrepreneurial experience.  Investments have spanned all business stages (from seed to mature) across numerous industry sectors.  Chris is a serial entrepreneur having founded, built, and led multiple companies.   

He holds a B.S. in Finance and Accounting from Ithaca College and an MBA from the William E. Simon Graduate School of Business Administration at the University of Rochester.  Chris is a Board Member of the Wegman Family Foundation and serves on the Safar Partners Advisory Board. 

Bijan Salehizadeh has 20 years of healthcare operating and investment experience. At NaviMed, he sits on the firm’s Investment Committee and is responsible for leading investments and overseeing portfolio companies with a particular focus on healthcare providers and pharmaceutical services. Prior to co-founding NaviMed Capital, he was a General Partner at Highland Capital Partners, where he focused on growth stage healthcare investments.

Prior to joining Highland Capital Partners in 2004, Dr. Salehizadeh spent several years in a variety of healthcare operational roles at publicly traded and emerging growth companies.

Dr. Salehizadeh led NaviMed’s investments in and currently serves on the Board of Directors of CenterPointe Behavioral Health System, The CM Group, Scientific Commercialization, and Velocity Clinical Research. He also serves on the Board of Directors of OPN Healthcare. Dr. Salehizadeh previously served on the Board of Directors of several companies including Auris Health (sold to Johnson & Johnson for $5.7 billion), BARRX Medical (sold to Covidien for $400 million), Hyperion Therapeutics (IPO; sold to Horizon plc for $1.1 billion), Lumere (sold to GHX), and Opgen (IPO). In addition, he has sourced or been actively involved in Highland Capital Partners’ investments in AVEO (IPO), Baronova, Conor Medsystems (IPO; sold to Johnson & Johnson for $1.4 billion), kyruus, and Pharmaca Integrative Pharmacy.

Dr. Salehizadeh holds an AB in Molecular Biology from Princeton University, an MD and Master’s in Science in Health Policy from Columbia University, and an MBA from Harvard Business School. He is also a graduate of the Kauffman Fellows Program.

Mark Zupan was selected as the 14th President of Alfred University on February 11, 2016 and took office on July 1, 2016.

Prior to that, he was Dean of the University of Rochester’s Simon Business School for ten years, after which he served for two years as the John M. Olin Distinguished Professor of Economics and Public Policy and Director of the Bradley Policy Research Center at the Simon School. He had previously served as the Dean of the University of Arizona’s Eller College of Management for seven years. While Dean at the Simon Business School, he championed an $85 million fundraising campaign that added 9 new endowed professorships, quadrupled philanthropic support for scholarships, and more than doubled annual discretionary giving; the campaign ultimately raised more than $96 million. He also established an undergraduate business program in partnership with the College of Liberal Arts & Sciences; pioneered specialized masters programs in finance, marketing, accounting, business analytics, and medical management; and doubled overall graduate student enrollment at Simon.

Holds a Bachelors degree from Harvard University, and his PhD from Massachusetts Institute of Technology.

Our Portfolio

5x5 Technologies

Remote monitoring of physical assets

Agility Robotics


Bipedal robots

Aramis Biosciences


Therapeutics for dry eye disease

Boston Meats


Creating the right taste and texture in alternative meats

5×5 TECHNOLOGIES develops software to reinvent inspection of physical equipment in the field. Their software solutions convert visual information like photographs and videos taken by drones into interactive 3D models. This tool allows their customers to analyze and maintain equipment like cell phone towers in the field, replacing dangerous and costly manual inspections.


AGILITY ROBOTICS manufactures highly capable legged robots. Their latest model, Digit, can walk, navigate, and carry boxes to perform simple tasks with minimal or no additional programming. Agility is exploring use cases in diverse markets such as last-mile logistics, telepresence, automated inspection, entertainment, and academic research


ARAMIS BIOSCIENCES is committed to the development of therapeutics in the area of ocular inflammation and pain. In order to address this domain, Aramis is producing therapeutics to address dry eye disease (DED).

Boston Meats makes meat using the building-blocks of life: proteins. Inspired by Nature, we make alternative meats with the right taste and texture – all at an affordable cost. 


C2 Sense


Advanced sensing solutions for a healthier and safer world  

Clerio Vision

University of Rochester

Vision correction enabled by laser technology



Real-Time Voice AI to Augment Emotional Intelligence

Commonwealth Fusion Systems


Commercial fusion energy systems for clean power generation

C2SENSE uses nanotechnology and advanced chemical engineering techniques to offer authentication, product viability assurance, and pathogen detection, enabling clients with reduced loss and harm in the food packaging, shipping, pharmaceutical, and luxury goods sectors. 


CLERIO VISION provides vision correction solutions enabled by next generation laser technology. These solutions include customizable contact lenses as well as non-invasive alternatives to conventional LASIK and cataract surgery.


COGITO is an AI company that augments emotional intelligence and helps elevate human performance. Their real-time, streaming voice AI instantly analyzes hundreds of conversational behaviors and emotions to provide live in-call guidance to contact center agents and real-time measurement of customer experience. 


COMMONWEALTH FUSION SYSTEMS is an energy company aiming to commercialize fusion energy production to take advantage of the extraordinary market opportunity for carbon-free power. CFS is applying a new class of superconducting magnets that will drastically reduce the size and cost of fusion power plants.


Concerto Biosciences


Microbial therapeutics

EagleDream Technologies


Cloud transformation and software solutions

Embr Labs


Wristwear device to change customers’ perception of temperature



Biomaterials for improved drug delivery

Microbiomes—complex, bustling ecosystems of bacteria, fungi, and viruses—influence the health of every person, plant, animal, and environment. When a microbial ecosystem loses one of its key functions, it can contribute to the onset or progression of recurrent infection, chronic inflammation, and other disease states. Using a novel screening tool called kChip, Concerto Biosciences creates microbial Ensembles, combinations of microbes that restore beneficial functions to a microbiome, healing people, plants, and the planet. Concerto’s first products will treat skin disorders like eczema, allowing hundreds of millions of people globally to enjoy a life free from inflamed, itchy skin.


EAGLEDREAM TECHNOLOGIES migrates and develops software for cloud computing technologies in order to provide value for their customers.  They are an Amazon Web Services (AWS) Premier partner.


EMBR LABS is the global leader in temperature-regulating wearable devices. These wearable devices can make users feel 5 degrees F warmer or cooler within minutes. Customers currently use the Embr devices for treatment of hot flashes, stress disorders, and sleep discomfort.


GELMEDIX develops solutions for drug delivery. GelMEDIX can replace today’s drug regimens that require application of eye drops 4-12x per day over several weeks with a single, non-invasive gel patch. GelMEDIX’s gel could also be used as a drug-eluting sealant for other wet mucosal surfaces, like the ear or mouth, and could be adapted for post operative work, including as a heart or lung sealant

Gradiant Corp.


Water treatment and recycling systems for more sustainable business practices.

Health Care Originals

University of Rochester

Remote respiratory monitoring device for better healthcare

Honeoye Remedies

University of Rochester

Scientific advancements for natural skin care



Data analytics and AI to make companies more productive

GRADIANT CORP. delivers industrial water treatment solutions to customers globally through its parent company and four subsidiaries. Their diverse line of solutions combine to form the most attractive technology portfolio in the water treatment industry and can handle even the most problematic waste streams.


HEALTH CARE ORIGINALS is a digital health company developing wearable devices that transcribe sounds inside the body into electronic signals. In combination with HCO’s mobile application, the device can be used to monitor and manage respiratory diseases, including helping to prevent asthma attacks.


HONEOYE REMEDIES, a subsidiary of Arcum Therapeutics, is developing all-natural skin care. Using the antibiotic properties of Manuka honey and tea tree oil, its products speed up wound healing and can be applied to rashes, scrapes, dry skin, and other skin irritations.


HUMANYZE is an AI company that uses data analytics to measure and improve the organizational health of companies, making them more efficient and productive. Through their use of sensors and AI technology, Humanyze analyzes existing corporate data to drive actionable organizational health scores that help companies make objective and informed decisions.


Imago Rehab


Digital health solution for physical rehab



Turn Key MEMS Microfabrication Solution



AI-enabled automated materials discovery



Manufacturer of conducting metal inks

Imago Rehab enables superior hand recovery outcomes for stroke survivors through a combination of home-use wearable robotics and digital health. Their first product is a soft robotic glove that allows stroke survivors to complete high-intensity rehab from the comforts of home along with personalized coaching through telehealth sessions with occupational therapists. 


InchFab provides on-demand custom chip manufacturing services for IoT and Beyond Compute sensor industries. InchFab’s proprietary microFoundry lines are rapidly reconfigurable to meet customer specifications while also allowing for quick turnaround fabrication.  


KEBOTIX is a technology company combining artificial intelligence and robotics to form a self-driving laboratory for materials discovery. Closing the loop between computer simulations and materials manufacturing speeds up the discovery process 10-100X for developing new materials.


LIQUIDX PRINTED METALS is developing water-based inks that can be printed on a wide range of substrates and can be cured to leave behind metallic films. As these metallic prints are conducting, the LiquidX ink can be used to integrate electronics into everyday objects in an easy to implement and cost-efficient manner.


Lucy Therapeutics


Pathology as a driver for therapy


UC Berkeley

Additive technology for advanced industrial applications

Pirouette Medical

MIT & Harvard

They make injections easy!



Millimeter wave drilling systems

LUCY THERAPEUTICS develops chemical therapeutics to treat mitochondrial dysfunction.  Mitochondrial dysfunction, caused by disease, may contribute to the complex pathology seen in certain diseases like Rett Syndrome, Parkinson’s, Alzheimer’s and COVID-19.

NELUMBO is an advanced materials company developing high-performance surface modifications for industrial surfaces (metal, glass and fabric). First applications are in refrigeration and HVAC for residential and commercial heat pumps where Nelumbo has first customers.


Pirouette Medical has developed and is bringing to market a revolutionary auto-injector. Auto-injectors are automated injection systems designed to allow self- or caregiver- administration; even by untrained individuals. Pirouette is initially developing an epinephrine auto-injector (EAI), which is used for the emergency treatment of severe allergic reactions. Existing EAIs leave patients actively seeking an alternative to address the anxiety they feel, associated with the affordability, portability, and usability of existing devices. Pirouette Medical is answering that call for something better, delivering a new EAI to revolutionize the marketplace and the overall patient experience. The patented device is portable, intuitive, and easy-to-use. Pirouette is poised to deliver a device that addresses all the major pain points through our human-centered design focus. Beyond EAIs, Pirouette’s technology is diversely applicable to many drugs that require fixed-dose, single-use intramuscular, or subcutaneous injections.


QUAISE is developing and commercializing novel millimeter wave drilling systems to harness geothermal energy around the globe, overcoming the geographic constraints limiting this energy source today. Quaise’s technology enables the clean energy transition by accessing the largest source of power-dense clean energy on Earth.

Radical Plastics


Biodegradable plastics

Riff Analytics


AI-enabled feedback to improve interactions

Righthand Robotics


Autonomous piece-picking robotic solutions



Lightweight, flexible solar cells

RADICAL PLASTICS has developed a patented catalyst that renders conventional plastics biodegradable in the natural environment. Items made from the Radical Plastics compound perform just like regular plastics. But if they end up in the environment, the free radical catalyst converts the plastic into a material that microbes recognize as food.


At Riff Analytics, we build tools that use AI to measure and augment human interactions, helping people and organizations communicate, collaborate, and innovate better. The Riff Platform includes a video collaboration tool that helps organizations improve team performance in online courses and corporate meetings by raising awareness of team dynamics and increasing engagement. Riff analyzes conversation patterns that reveal the subtle behaviors between colleagues, such as influence and dominance, and then provides the coaching necessary for participants to improve their behavior in meetings leading to better team performance. 


RIGHTHAND ROBOTICS creates robots that can grasp products of different sizes, shapes, and weights. The combination of suction cups and compliant finger-like grippers handles a wide range of objects efficiently, and their cameras and machine-learning capacities allow the robots to learn from past mistakes.


SWIFT SOLAR is developing lightweight, flexible solar cells to enable efficient, low-cost photovoltaics that can be deployed easily and swiftly wherever solar energy is needed. The initial applications are being developed for drones and electric vehicles.


Ubiquitous Energy


Transparent solar panels

Verve Motion


Flexible exosuits for industrial applications

Via Separations


Membrane based filtration

Xibus Systems


Rapid bacteria detection for improving food safety

UBIQUITOUS ENERGY is one of the world leaders in transparent photovoltaics and is developing the first truly transparent solar technology. The combination of energy conversion and transparency will create windows that generate electricity from the sun without aesthetic impairment.


Verve Motion is the developer of SafeLift. The technology behind SafeLift has been developed at Harvard over the past decade, and is based on the latest advances in robotics, apparel design, and movement science. The suit applies assistance in parallel with the user’s muscles and responds to their movement in milliseconds. It combines state-of-the-art motion tracking technology with powerful robotic actuators and integrates it all into a lightweight and easily wearable device that doesn’t restrict normal activities. 

The result is a device that takes 30% of strain off of people when they perform physically strenuous tasks, supporting the back and hips to reduce risk of injury, improve lifting form and posture, and greatly lower fatigue and soreness. Even better, it is incredibly simple to integrate our system into your workplace: it takes less than 30 seconds to put on, one size fits most, and the suit is ready to wear right out of the box. 


VIA SEPARATIONS is a membrane company applying novel filtration to reduce the energy used in industrial separation processes by 90%. With applications across food and beverage, pulp and paper, pharmaceuticals, and chemical production, Via is targeting the 10% of global energy consumption that is wasted in thermal separation processes.


XIBUS SYSTEMS is a biomaterials company developing rapid bacteria-testing analytics. Using its detection technology, Xibus will improve food safety and cut losses due to contaminated food along the entire supply chain.



Big data meets geothermal exploration

Zanskar is a technology company combining big data, machine learning, and advanced seismic imaging to develop the first full-stack AI platform for discovering geothermal resources and de-risking their development. 


Recent news

Safar Partners is committed to funding technological advances that create value.


Interested in partnering with us?

Contact Information

Safar Partners
One Broadway, 14th floor, 
Cambridge, MA 02142